Tongyuan Pharma (02410.HK) nominated TY-3002, a next-generation oral small molecule GLP-1R agonist, as preclinical candidate. The compound shows 54.6% better weight loss efficacy than Orforglipron with improved fat reduction and muscle preservation.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 25 of 518
Get full access to view complete information
Frequently Asked Questions Regarding 香港交易所
Company Overview
2000
Founded
Financial Services
Industry
Hong Kong
Location
21,789
Ranking
10,100 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding 香港交易所
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.